The treatment of experimental mouse hemoblastosis IV. Thearapy of leukemia L 14 AKR with drugs of demonstrated or potential cytostatic effects.
D000738:Androsterone / Q000627:therapeutic use*; D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008775:Methylprednisolone / Q000627:therapeutic use*; D051379:Mice; D009705:Nucleosides / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use*
D000963:Antimetabolites; D009705:Nucleosides; D011687:Purines; D003609:Dactinomycin; D000738:Androsterone; D008775:Methylprednisolone